Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3OUH

PHD2-R127 with JNJ41536014

Summary for 3OUH
Entry DOI10.2210/pdb3ouh/pdb
Related3OUI 3OUJ
DescriptorEgl nine homolog 1, FE (II) ION, SULFATE ION, ... (5 entities in total)
Functional Keywordsphd2, oxidoreductase
Biological sourceHomo sapiens (human)
Cellular locationCytoplasm : Q9GZT9
Total number of polymer chains1
Total formula weight27011.83
Authors
Kim, H.,Clark, R. (deposition date: 2010-09-14, release date: 2010-12-01, Last modification date: 2018-04-18)
Primary citationRosen, M.D.,Venkatesan, H.,Peltier, H.M.,Bembenek, S.D.,Kanelakis, K.C.,Zhao, L.X.,Leonard, B.E.,Hocutt, F.M.,Wu, X.,Palomino, H.L.,Brondstetter, T.I.,Haugh, P.V.,Cagnon, L.,Yan, W.,Liotta, L.A.,Young, A.,Mirzadegan, T.,Shankley, N.P.,Barrett, T.D.,Rabinowitz, M.H.
Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues.
ACS Med Chem Lett, 1:526-529, 2010
Cited by
PubMed Abstract: HIF prolyl 4-hydroxylases (PHD) are a family of enzymes that mediate key physiological responses to hypoxia by modulating the levels of hypoxia inducible factor 1-α (HIF1α). Certain benzimidazole-2-pyrazole carboxylates were discovered to be PHD2 inhibitors using ligand- and structure-based methods and found to be potent, orally efficacious stimulators of erythropoietin secretion in vivo.
PubMed: 24900242
DOI: 10.1021/ml100198y
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.51 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon